A significant breakthrough in cancer research is arising with the use of mini-antibodies to re-engage mutated p53. This essential cancer protector protein is frequently disabled in various forms of tumors, leading https://bookmarkahref.com/story21935311/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-approach-for-cancer-treatment